OnCore Login

Return to Trial Database

HCRN-BRE99-1

Phase II Trial of Gemcitabine, Paclitaxel and Trastuzumab in Metastatic Breast Cancer: a Hoosier Oncology Group Trial

Status

Study Completed

Cancer Type(s)

Breast

Study Contact

Publications

Phase II study of gemcitabine, paclitaxel and trastuzumab in metastatic breast cancer
  • KD Miller, J Sisk, G Gize, S Nattam, R Ansari, J Vinson, G Sledge
Phase II Study of Gemcitabine, Paclitaxel and Trastuzumab in Metastatic Breast Cancer
  • KD Miller, J Sisk, G Gize, S Nattam, R Ansari, J Vinson, G Sledge

Trial Locations

All sites in which the trial HCRN-BRE99-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278